Literature DB >> 6265346

Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.

J Cihak, H W Ziegler, E Kölsch.   

Abstract

The non-secreting variant of ADJ-PC-5 plasma cell tumour of BALB/c mice is a highly malignant tumor, the LD50 being 3 x 10(1) cells/mouse after intraperitoneal injection. Nevertheless, immunization against the tumour is possible. Four injections of 10(7) X-irradiated tumour cells at weekly intervals render up to 95% of mice resistant to an otherwise lethal challenge with 10(3) living tumour cells. The immune responses are both T cell-mediated cellular cytotoxicity and antibody-mediated cytotoxicity as assessed by in vitro tests. Immunity can also be transferred in vivo into recipient mice by either spleen cells or immune sera. Specificity of both types of immune responses was determined. The results indicate that the cell-mediated and the humoral immune response are directed against cell-surface antigens associated with endogenous murine leukemia virus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265346      PMCID: PMC1555172     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

Authors:  M Röllinghoff; B T Rouse; N L Warner
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

2.  Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.

Authors:  B T Rouse; M Röllinghoff; N L Warner
Journal:  Eur J Immunol       Date:  1973-04       Impact factor: 5.532

3.  Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.

Authors:  R B Herberman; T Aoki; M Nunn; D H Lavrin; N Soares; A Gazdar; H Holden; K S Chang
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

4.  Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.

Authors:  W H Williams; R G Krueger
Journal:  J Natl Cancer Inst       Date:  1972-12       Impact factor: 13.506

5.  Effect of intraperitoneal pristane on established immunity to the adj-PC-5 plasmacytoma.

Authors:  M Potter; J L Walters
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

6.  Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.

Authors:  R C Burton; N L Warner
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

7.  Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice.

Authors:  J L McCoy; J H Dean; L W Law; J Williams; N T McCoy; B J Holiman
Journal:  Int J Cancer       Date:  1974-08-15       Impact factor: 7.396

8.  Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses.

Authors:  J N Ihle; J J Domotor; K M Bengali
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

9.  Leukemia viruses associated with mouse myeloma cells.

Authors:  J Watson; P Ralph; S Sarkar; M Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

10.  Immune and natural antibodies to syngeneic murine plasma cell tumors.

Authors:  R B Herberman; T Aoki
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.